Camacho LH, Antonia S, Sosman J, et al. Phase I /II trial of tremelimumab in patients with metastatic melanoma. J Cli n Oncol. 2009;27(7):1075-81. 103. Topalian SL , Drake CG, Pardoll DM. I mmune checkpoint blockade: a common denominator approach to cancer therap y. Cancer Cell. 2015 Apr 13; 27(4):450 -61.